Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant
35 or More Weeks of Gestation | Pediatrics | American Academy of Pediatrics Skip to Main …

The nutritional and immunologic properties of human milk, along with clear evidence of dose-
dependent optimal health outcomes for both mothers and infants, provide a compelling …

Neonatal indirect hyperbilirubinemia (IHB) is caused by an imbalance in bilirubin production
and elimination. Approximately 60% of term and 80% of preterm infants develop jaundice in …

BACKGROUND: In-hospital formula feeding (IHFF) of breastfed infants is associated with
shorter duration of breastfeeding. Despite evidence-based guidelines on when IHFF is …

There is a paucity of literature exploring the challenges of breastfeeding sick children in
hospital. Previous research has focused on single conditions and hospitals which limits …

More than two-thirds of infants develop jaundice, the clinical manifestation of
hyperbilirubinemia. Most cases are physiologic and benign. All newborns should be …

Background Neonatal jaundice occurs in approximately 60% of term newborns. Although
risk factors for neonatal jaundice have been studied, all the suggested strategies are based …

Late preterm (LP) and early term (ET) infants can be considered the “great dissemblers”:
they resemble healthy full-term infants in appearance, but their immaturity places them at …

In‐hospital infant formula supplementation of breastfed infants reduces breastfeeding
duration, yet little is known about common reasons for infant formula supplementation. We …

Meta-analyses consistently find a substantial possible association between neonatal
jaundice (hyperbilirubinemia) and later autism risk. The obvious question this poses is" what …